AI startup Lunit from South Korea has bagged $26 million in a Series C Tranche B funding round. The investment came from Guardant Health, a Nasdaq-listed precision oncology firm.
WHAT IT DOES
Founded in 2013, Lunit develops AI software in the oncology space. Its solutions are designed to discover cancer and predict cancer treatment outcomes.
One of its tech solutions, tissue analysis platform...
Global biopharmaceutical company, AstraZeneca has announced a partnership through its Emerging Markets Health Innovation Hubs programme, with India-based AI solution provider, Qure.ai.
The partnership aims to to integrate AI solutions for the early detection of lung cancer in patients across AstraZeneca’s Emerging Markets regions, covering Latin America, Asia and the Middle East & Africa.
WHY...
